Ipca Laboratories Ltd.
Research Ipca Laboratories Ltd. (IPCALAB.NS) on Bullrun: market cap INR 496.58B, P/E 35.4, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIPCALAB.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 496.58B
- P/E35.4
- Dividend yield0.3%
- Financial periodQ2 2026
- RevenueINR 27.88B
- Net incomeINR 4.02B
- Gross margin71.4%
Valuation Snapshot
latest market cap is INR 496.58B; P/E is 35.4; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 35.41x versus a Healthcare sector median of 21.8x (62.5% above).
Latest dividend yield is 0.31% versus a Healthcare sector median of 2.4% (87.1% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | INR 496.58B | 35.4 | 0.3% | 6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 6 INR, yield 0.3%.
About Ipca Laboratories Ltd.
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas.
ETFs that hold Ipca Laboratories Ltd.
US-listed ETFs
Ipca Laboratories Ltd. is held by 30 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | 0.02% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | 0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | 0.02% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | 0.01% | 0.04% |
| iShares Core MSCI Total International Stock ETF (IXUS) | 0.01% | 0.07% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Schwab Emerging Markets Equity ETF (SCHE) | 0.02% | 0.06% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ipca Laboratories Ltd.'s market cap?
Ipca Laboratories Ltd.'s market capitalization is INR 496.58B.
What is Ipca Laboratories Ltd.'s P/E ratio?
Ipca Laboratories Ltd.'s price-to-earnings (P/E) ratio is 35.4.
Does Ipca Laboratories Ltd. pay a dividend?
Ipca Laboratories Ltd. has a dividend yield of 0.3%.
What does Ipca Laboratories Ltd. do?
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas.